John Wayne Cancer Institute

Santa Monica, California 90404

0 studies enrolling now · 56 studies all time

What they study most

Adenocarcinoma of the Prostate, Advanced Malignancies, Advanced Melanoma, Anaplastic Astrocytoma, Bladder Cancer, Brain Cancer, Brain Metastases, Brain and Central Nervous System Tumors, Breast Cancer, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Studies at this site

• White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA — Paused
• Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) — Stopped early
• Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence — Completed
• A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma — Completed
• Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer. — Completed
• Phase IIB TL + YCWP + DC in Melanoma — Completed
• Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer — Completed
• The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies. — Stopped early
• Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer — Completed
• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma — Paused
• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy — Completed
• Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma — Completed
• Trial of pIL-12 Electroporation Malignant Melanoma — Completed
• CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early
• Pemetrexed for the Treatment of Chordoma — Completed
• Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA) — Completed
• Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) — Completed
• Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab — Completed
• Multicenter Selective Lymphadenectomy Trial II (MSLT-II) — Completed
• Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases — Completed
• Safety Study of Afatinib for Brain Cancer — Completed
• Studying Lymph Nodes in Patients With Stage II Colon Cancer — Status unconfirmed
• A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208) — Stopped early
• Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients — Status unconfirmed
• Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma — Status unconfirmed
• A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas — Stopped early
• A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis — Completed
• A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain — Completed
• Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma — Withdrawn before enrolling
• Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas — Stopped early
• Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors — Completed
• POA Prospective Repository — Status unconfirmed
• An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma — APPROVED_FOR_MARKETING
• Transsphenoidal Extent of Resection Study — Completed
• Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration — Stopped early
• Minimally Invasive Groin Dissection for Melanoma — Completed
• TR(ACE) Assay Clinical Specimen Study — Status unconfirmed
• Effects of Acupuncture on Aromatase Inhibitor-Induced Joint Pain — Completed
• Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma — Withdrawn before enrolling
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer — Completed
• Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma — Stopped early
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
• Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer — Completed
• IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma — Status unconfirmed
• Nutrition Intervention in Treating Women With Breast Cancer — Completed
• Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer — Completed
• Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes — Completed
• Irofulven in Treating Patients With Stage IV Melanoma — Completed